Chase Cannon
Overview
Explore the profile of Chase Cannon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chu V, Glascock A, Donnell D, Grabow C, Brown C, Ward R, et al.
Nat Med
. 2024 Oct;
31(1):207-217.
PMID: 39363100
Doxycycline post-exposure prophylaxis (doxy-PEP) reduces bacterial sexually transmitted infections among men who have sex with men and transgender women. Although poised for widespread clinical implementation, the impact of doxy-PEP on...
2.
Cannon C, Holzhauer K, Golden M
JMIR Res Protoc
. 2024 Sep;
13:e56587.
PMID: 39312771
Background: HIV prevention is a public health priority. Despite progress in recent years, pre-exposure prophylaxis (PrEP) use remains suboptimal especially among groups disproportionately impacted by new HIV diagnoses such as...
3.
Celum C, Cohen S, Dombrowski J, Cannon C, Luetkemeyer A
Sex Transm Dis
. 2024 Aug;
51(9):597-598.
PMID: 39150124
No abstract available.
4.
Langelier C, Chu V, Glascock A, Donnell D, Grabow C, Brown C, et al.
Res Sq
. 2024 May;
PMID: 38699315
Doxycycline post-exposure prophylaxis (doxy-PEP) reduces bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women. While poised for widespread clinical implementation, the impact of doxy-PEP...
5.
Fredericksen R, Perkins R, Brown C, Cannon C, Lopez C, Cohee A, et al.
AIDS Patient Care STDS
. 2024 Apr;
38(4):155-167.
PMID: 38656217
Doxycycline postexposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) in men who have sex with men (MSM) and transgender women (TGW). In a clinical trial of doxy-PEP, we sought to...
6.
Golden M, Soge O, Mills M, Berzkalns A, Cannon C, Ramchandani M, et al.
Sex Transm Dis
. 2024 Feb;
51(5):342-347.
PMID: 38301634
Background: How often mpox causes asymptomatic infections, particularly among persons who have received the Modified Vaccinia Ankara (MVA) vaccine, is unknown. Methods: We performed mpox polymerase chain reaction testing on...
7.
Luetkemeyer A, Cannon C, Celum C
N Engl J Med
. 2023 Jul;
389(3):286-287.
PMID: 37467511
No abstract available.
8.
Cannon C, Celum C
Lancet Infect Dis
. 2022 Jun;
22(8):1103-1105.
PMID: 35643091
No abstract available.
9.
Bagrodia A, Youssef R, Kapur P, Darwish O, Cannon C, Belsante M, et al.
Eur Urol
. 2012 May;
62(1):e27-9.
PMID: 22552216
No abstract available.